![Vinay Bhaskar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vinay Bhaskar
Nessuna posizione attualmente
Profilo
Vinay Bhaskar served as a Director at Amphivena Therapeutics, Inc. and Tizona Therapeutics, Inc. He was also the Principal at MPM BioImpact, Inc from 2016 to 2021.
Bhaskar served as the Chief Operating Officer at Werewolf Therapeutics, Inc. and Turmeric Acquisition Corp.
Bhaskar holds a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California, Davis.
Precedenti posizioni note di Vinay Bhaskar
| Società | Posizione | Fine |
|---|---|---|
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Direttore/Membro del Consiglio | 01/09/2021 |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Investitore di Private Equity | 01/07/2021 |
| TURMERIC ACQUISITION CORP. | Direttore operativo | 30/04/2021 |
| WEREWOLF THERAPEUTICS, INC. | Direttore operativo | - |
Amphivena Therapeutics, Inc.
 Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Direttore/Membro del Consiglio | - |
Formazione di Vinay Bhaskar
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
26
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amphivena Therapeutics, Inc.
Amphivena Therapeutics, Inc. BiotechnologyHealth Technology Develops clinical-stage immuno-oncology therapeutics | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
